Stan Chamberlain

Stan Chamberlain

Company: T3D Therapeutics

Job title: Chief Scientific Officer


Deep Diving into the Development of a PPAR Delta/Gamma Agonist T3D-959 for Alzheimer’s Disease 4:30 pm

Understanding the PPAR rational in Alzheimer’s Disease Revealing the latest pre-Clinical and early clinical data for T3D-959 Showcasing ongoing PIONEER Phase 2 Study with T3D-959Read more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.